Related Experiment Video
Updated: Jul 9, 2026
10:08
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
[Dilated cardiomyopathy and syncope: management].
1Service Cardiologie, CHU de Brabois, Vandoeuvre-lès-Nancy. b.brembilla-perrot@chu-nancy.fr
Archives Des Maladies Du Coeur Et Des Vaisseaux
|November 23, 2007
Summary
Syncope in dilated cardiomyopathy has multiple causes, including ventricular tachycardia. Management strategies for syncope vary based on the cause and heart disease severity, often involving advanced cardiac technologies.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure
Context:
- Syncope is a significant symptom in patients with primary dilated cardiomyopathy.
- Identifying the precise cause of syncope is crucial for effective management.
- Dilated cardiomyopathy presents complex challenges due to potential arrhythmias and reduced cardiac function.
Purpose:
- To outline the diverse etiologies of syncope in dilated cardiomyopathy.
- To delineate management strategies based on syncope cause and cardiac disease severity.
- To provide guidance on diagnostic and therapeutic interventions for syncope in this patient population.
Summary:
- Syncope in dilated cardiomyopathy stems from ventricular tachycardia (VT), supraventricular tachycardia, bradycardia, or vagal hyperactivity.
- For patients with left ventricular ejection fraction (LVEF) <30% and adequate life expectancy, non-drug therapies like defibrillators with or without resynchronization are considered.
- Electrophysiology studies are key for patients with LVEF >30% to identify syncope etiology, with Holter monitoring reserved for recurrent syncope after negative electrophysiology studies.
Impact:
- This information aids clinicians in tailoring syncope management for dilated cardiomyopathy patients.
- Improved diagnostic and therapeutic approaches can lead to better patient outcomes and reduced syncope recurrence.
- Highlights the importance of integrating electrophysiological assessment with cardiac function evaluation for optimal care.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...